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Objectives Susceptibility to heroin dependence is strongly influenced by genetic factors with heritability estimates as high as 0.7. A number of genes, as well as environmental factors, are likely to contribute to its etiology. Not all individuals who have ever tried heroin at some stage during their lifetime become dependent on heroin. It has been suggested that genetic factors might be more important in the transition stage to heroin dependence rather than in environmental exposures and experimenting with heroin. As the features of substance dependence and memory formation have been found to be strikingly similar, we have focused on a key enzyme involved in long-term potentiation and synaptic plasticity, namely the calcium-dependent/calmodulin-dependent protein kinase IIα (CAMKIIa). We hypothesized, that CamK2A genetic variation may play a role in the transition from occasional to regular heroin use.
Materials and methods
Using quantitative trait association analysis, we addressed this hypothesis by correlating the self-reported time interval between occasional and regular heroin use with the frequency of 12 single nucleotide polymorphisms located within the genomic region of the CamK2A gene. A sample of 570 Caucasian patients was available for analysis.
Results Single marker association analysis (rs10066581, P = 0.007), as well as haplotype analysis (global P = 0.005), suggested an association with the quantitative trait 'time interval from occasional to regular heroin use. '
Conclusion Our results propose that genetic variants located in the genomic region of the CamK2A gene may be involved in transition time from occasional to regular heroin use. Psychiatr Genet 29:18-25 Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Heroin is a narcotic drug with a high potential to induce severe substance dependence. Results from the National Comorbidity Survey in US adolescents indicated that the number of individuals who have started using heroin is continuously on the rise since 2007 (Substance Abuse and Mental Health Services Administration, 2014). As heroin is regularly injected, there is a high risk of serious infectious diseases in users, such as hepatitis, or AIDS, increasing the disease burden on individuals and society (Nutt et al., 2010) .
Although heroin dependence and other substance dependence disorders are obviously driven by lifestyle choices, genetic factors have been shown to play a substantial role in the etiology as well (Merikangas et al., 1998; Tsuang et al., 1998) . Heritability to heroin dependence is most likely multifactorial with a large number of susceptibility genes contributing to the etiology. Notably, it has been suggested that environmental factors are more important for occasional drug use than for regular drug abuse and dependence (Kendler et al., 2003) . In essence, drug dependence disorder is thought to be a multistep transition where initiation of drug use, most likely, is more influenced by environmental factors, whereas the transition from use to dependence may be more influenced by genetic factors. Therefore, we hypothesized that the investigation of genetic factors Antonia Eirich: The present work was performed in (partial) fulfilment of the requirements for obtaining the degree 'Dr.med'. Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.psychgenetics.com.
involved in the transition from initial to regular (compulsory) heroin use may provide insights into the factors leading to heroin dependence.
Genes involved in memory formation could possibly play a key role in this transition. Addiction and memory formation has been found to be strikingly similar in animal models. Both addiction and memory exert their main effects in similar brain regions including the hippocampus, amygdala, and the prefrontal cortex (Kelley, 2004; Koob and Volkow, 2010) . In addition, molecular changes, such as changes in gene expression, in epigenetic regulation, as well as in synaptic plasticity, and neuronal morphology are strikingly similar in addiction and in the formation of memory (Hyman et al., 2006; Nestler, 2013) . Thus, it is hypothesized that development of addiction could be related to a process of reward learning, leading to compulsive seeking, abuse, and an increased susceptibility to relapse (Kelley, 2004; Kauer and Malenka, 2007) .
One key molecule involved in memory formation is the calcium/calmodulin-dependent protein kinase (CaMKII), which is a serine/threonine protein kinase. The enzyme is an oligomeric protein, composed of distinct but related subunits encoded by separate genes. Function and dysfunction of CaMKII have been recently the subject of research in psychiatric disorders including addiction (Robison, 2014) . CamK2A, the α isoform of CaMKII is a calcium/calmodulin-activated enzyme and is located on human chromosome 5q32. It has been mainly studied in chronic amphetamine and cocaine abuse, and more recently also in alcohol addiction (Robison, 2014; Muller et al., 2016) . The enzyme is enriched in synapses and is thought to be a main component of the postsynaptic density where it is bound to N-methyl-D-aspartatereceptors (NMDAR). Interaction of CaMKII with the GluN2B subunit of the NMDAR seems to be crucial for synaptic strengthening and memory consolidation (Barria and Malinow, 2005; Shipton and Paulsen, 2014) . A mouse model, in which CaMKII binding to the NMDAR GluN2B subunit was impaired through the introduction of two mutations in the GluN2B subunit, showed deficits in early memory consolidation in the Morris water maze test, whereas the overall learning was quite normal. Thus, it had been concluded that the interaction of CaMKII with GluN2B might be important for the early phases of contextual memory consolidation and maintenance (Halt et al., 2012) .
We hypothesized that genetic variation in CamK2A may play a role in the transition from casual to regular and uncontrolled heroin use. We addressed this hypothesis by correlating the self-reported time interval from first to regular heroin use with the frequency of 12 single nucleotide polymorphisms (SNPs) located within the genomic region of the CamK2A gene. We had a sample of 684 Caucasian patients with heroin dependence available. We used quantitative trait association analysis for correlating the self-reported transition interval from first to regular heroin use with genetic variants in the CamK2A gene.
Materials and methods

Study sample
Individuals with heroin dependence were identified by the Fresh Start Recovery Program in Perth, Australia, for the Western Australian Study on Heroin Dependence. The study was approved by the Human Research Ethics Committee of the University of Western Australia (RA/ 4/1/1814) and was carried out in accordance with the latest version of the Declaration of Helsinki (World Medical Association, 2013) . Informed consent was obtained from each individual, and heroin dependence was confirmed using the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) (American Psychiatric Association, 2000) criteria. Study participants were asked to complete a questionnaire, including questions on ethnicity, age at first use of heroin, years of overall use of heroin, time interval between occasional heroin use (less than once a week) and regular (i.e. daily) heroin use, previous treatment attempts and other legal and illegal drug use. All individuals underwent subsequent treatment with naltrexone implants within a research setting at the Fresh Start Recovery Program. Blood samples (anticoagulant EDTA), withdrawn during initiation for treatment, were used for DNA isolation, using standard procedures (Miller et al., 1988) . Before quality control for genotyping, 718 individuals with selfreported Caucasian ethnicity were included.
Genotyping
Genotyping of ancestry informative markers
A total of 87 ancestry informative markers have been identified from Enoch et al. (2006) and genotyped at the Path West at the Department of Molecular Genetics, Perth, Australia using Illumina Golden Gate assay with multisample Sentrix Array Matrix (Illumina, San Diego, California, USA). Genotypes were called using the GenomeStudio Genotyping Module v1.0 software from Illumina. SNPs were excluded when the Hardy-Weinberg equilibrium test revealed P less than 0.001, or genotyping rate was less than 0.9 (Supplementary Table 1 , Supplemental digital content 1, http://links.lww.com/PG/A210).
Selection and genotyping of SNPs in the genomic region of the CamK2A gene
The following criteria were used for selection of SNPs: (a) SNPs have to be relatively evenly distributed throughout the genomic region of the CamK2A gene, taking the block structure of the genomic region (identified using HaploView 4.2 and 95% confidence intervals; Gabriel et al., 2002) into account; (b) SNPs with a minor allele frequency of greater than 0.05 in Caucasian populations. A total number of 12 SNPs were selected (Table 1) . Genotyping was performed by either using self-designed PCR-RFLP assays, high-throughput fluorescence-based allelic discrimination assays (TaqMan SNP genotyping assay-by-demand; Applied Biosystems, Foster City, California, USA), or by using a self-designed high resolution melting (HRM) assay (Table 1 ). All genotyping assays included between 50 and 70 samples in duplicate for quality control.
TaqMan assays were performed according to the manufacturer's instructions in 384-well microtiter plates containing in each well 5 ng DNA, the locus-specific primer set, and 5 µl TaqMan Master Mix as supplied by Applied Biosystems. The reaction mixture was amplified using an Applied Biosystems 7900 Real-Time PCR system (Applied Biosystems). Allele discrimination was done using the Sequence Detection Software v2.1 (Applied Biosystems).
Primers for PCR-RFLP assays were designed using the Primer3 Web software (Koressaar and Remm, 2007; Untergasser et al., 2012) and ordered from Eurofins MWG Operon, Ebersberg, Germany. PCRs were performed using 0.5 µmol/l of forward and reverse primer respectively (Supplementary Table 2 , Supplemental digital content 2, http://links.lww.com/PG/A211), 12.5 ng DNA, 200 µmol/l dNTPs, 1.25 U Taq polymerase (Qiagen, Hilden, Germany), and 2 µl buffer provided by Qiagen in a total volume of 20 µl. Cycling conditions with annealing temperatures as outlined in Supplementary Table 2, Supplemental digital content 2, http://links.lww. com/PG/A211, were 5 min denaturation at 95°C followed by 30 cycles, each cycle consisting of 30 s denaturation at 95°C, 40 s annealing, and 60 s elongation at 72°C. A final extension step was included consisting of 10 min at 72°C. Restriction enzymes were purchased from New England Biolabs (Frankfurt/Main, Germany), and digestion was performed by adding 0.5 µl buffer (supplied by the manufacturer), 5 U of a specific enzyme (Supplementary  Table 2 , Supplemental digital content 2, http://links.lww. com/PG/A211), in a total volume of 20 µl. The mixture was incubated for 3 h at 37°C. Electrophoresis of the digested product was performed after application to a gel containing 2.5% agarose. Digested products were visualized after staining with ethidium bromide using ultraviolet light (302 nm). PCR-RFLP assays were also developed for TaqMan assays with less than 95% genotyping completeness (Table 1 ). For quality control and genotyping consistency, duplicated samples, comprising samples with known genotype, were included in these assays.
For SNP rs10463293, we developed an HRM assay for allele discrimination. Primer3 Web software (Koressaar and Remm, 2007; Untergasser et al., 2012) was used for selection of primers (Supplementary Table 2 , Supplemental digital content 2, http://links.lww.com/PG/A211), and the DINAMELT web server (Markham and Zuker, 2005) was used for analyzing the suitability of the PCR product for Table 1 Characteristics of single nucleotide polymorphisms including genotyping information HRM analysis. Primers were synthesized by Eurofins MWG Operon (Ebersberg, Germany). PCR reactions were performed in 10 µl, containing 0.7 µmol/l forward and 0.7 µmol/l reverse primer, 10 ng DNA, and Type-it HRM master mix (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. Cycling conditions, using a Roche Lightcycler480 (Roche Diagnostics, Penzberg, Germany) were as follows: 5 min denaturation at 95°C followed by 45 cycles, each cycle consisting of 10 s denaturation at 95°C, 30 s annealing/elongation at 57°C. Subsequent high resolution melting curve analysis was performed by heating to 65°C for 1 s, followed by continuous heating up to 95°C with a ramping rate of 0.02°C/s and 25 data acquisition points per second. After this, the samples were cooled to 40°C. The Roche Lightcycler480 Gene Scanning module was used for allele discrimination. Genotypes were allocated according to four reference samples, which had been sequenced using BigDye chemistry (Applied Biosystems) for allele identification.
Quality control
Quality control was based on genotyping information from ancestry informative markers (Supplementary  Table 1 , Supplemental digital content 1, http://links.lww. com/PG/A210) as well as on genotyping information for 12 locus-specific markers (Table 1) . Three samples were deleted because of failing genotyping completeness (< 0.9 in the 87 ancestry informative markers). To confirm the ethnic background, Eigenstrat analysis was applied. Study participants (N = 4), with more than 6 SDs outside of the mean for eigenvector 1 or eigenvector 2 were deleted. In addition, we applied the pairwise identity by decent information tool in PLINK to control for related or duplicated samples, which resulted in the deletion of another two samples. For 25 individuals, no information on quantitative parameters was available. The final sample consisted of 684 study participants (450 male and 234 female).
Statistical methods
GenomeStudio Genotyping Module v1.0 (Illumina) was used to analyze ancestry informative SNPs. SNPs with a GenTrain score of less than 0.6, a genotyping completeness of less than 0.9, and Hardy-Weinberg equilibrium of less than 0.001 were excluded. Single samples were excluded for further analysis when genotyping completeness across the SNPs was less than 0.9.
The program Eigenstrat (Price et al., 2006) was used for analysis of ancestral background and identification of ethnic outliers. For this purpose, genotype information was extracted for samples from the HapMap database for the CEPH population (CEU, N = 174), the Chinese population Beijing (CHB, N = 86), and the Yoruba in Ibadan, Nigeria (YRI, N = 175).
PLINK (Purcell et al., 2007) was used for analysis of quantitative phenotypes and genotypes, generating P values, which are based on a Wald test. As ethnic outliers had been removed before this analysis, no further covariates were used. In addition, we used the pairwise IBD detection tool implemented in PLINK for the identification of close relationships between individuals.
Haploview 4.2 (Barrett et al., 2005) was used for identification of the linkage disequilibrium (LD) block structure with 95% confidence intervals (Gabriel et al., 2002 ; Fig. 1 ).
Analysis of haplotypes was completed using FAMHAP Knapp, 2004a, 2004b; Herold and Becker, 2009 ). Table 2 provides further details for phenotypic characterization. Data on phenotypic characterization were available for 68-95% of the sample, depending on the parameter considered. Most of the individuals started using heroin in early to late adolescence. The average self-reported age of initiating heroin use was 19.6. More than 75% of them have been using heroin for more than 5 years. More than half of the individuals (53%) reported no time delay between occasional and regular heroin (Fig. 2) . Abuse of other illegal drugs was commonly reported. Moreover, most of the study participants had two or more treatment attempts for heroin use dependence in the past.
Results
Phenotypic parameters
Analysis using quantitative phenotype 'time interval from occasional to regular heroin use'
A total of 570 individuals were available for this phenotype. Three markers, rs4958468, rs10066581, and rs6869634 revealed nominal statistically significant P values (P = 0.03, 0.007, and 0.018, respectively) with the quantitative trait 'time interval from occasional to regular heroin use' (Table 3; see Supplementary Table 3 , Supplemental digital content 3, http://links.lww.com/PG/ A212, for sex-specific analysis). None of these P values survives multiple testing. Because of the small number of homozygote minor allele genotypic carriers (N = 3), the nominally significant association for rs4958468 was not considered to be informative. For rs10066581 (Table 3) , minor allele carriers showed a longer 'time interval from occasional to regular heroin use' (4.09 and 2.18 years for homozygote and heterozygote minor allele carriers, respectively). In contrast, for rs6869634, carriers of the major allele showed an association with a longer time interval (2.04 and 1.44 years for homozygote and heterozygote major allele carriers, respectively) ( Table 3) . As rs10066581 and rs6869634 are located in the same haplotype block (Fig. 1) , we investigated whether haplotype analysis could support the nominal association of minor and major allele in the same haplotype block.
We performed haplotype trend regression as implemented in FAMHAP for an overall estimation of association of haplotypes on the basis of markers located in LD block 2 (block 2: rs10066581 and rs6869634; Fig. 1 ). A global P value of 0.0054, which is corrected for the global null hypothesis that none of the marker combinations tested is associated, was produced. To obtain more information on the nature of this association, we extracted haplotypes that were generated by FAMHAP on the basis of the expectation-maximization algorithm. Only haplotypes with a frequency of more than 0.01 and a likelihood weight more than 0.99 were included in this post-hoc exploratory analysis. Our investigation focused on carriers of haplotype '3,' composed of the minor allele for rs10066581 and the major allele for rs6869634, as this allele combination was implicated by initial analysis in PLINK. Descriptive statistics (Table 4 ) revealed a longer 'time interval from occasional to regular heroin use' for carriers of haplotype '3' with an average of 2.32 years. In contrast, noncarriers of haplotype 3 revealed a shorter time interval (average: 1.61 years).
Discussion
In the present paper, we describe an investigation of a possible influence of genetic variants in the gene for CamK2A on the 'time interval from occasional to regular heroin use' using quantitative trait analysis. The main finding of our study was the nominal association of the minor allele of SNP rs10066581 (A-allele) with a longer 'time interval from occasional to regular heroin use'. As a quantitative phenotype, we used a self-reported parameter, namely the elapsed time between occasional and regular heroin use. Thus, in contrast to the classical case/ control design, where only the end point of heroin use is considered, we accounted for the multistaged process from initiation of heroin use to heroin dependence. We hypothesized, that this design should enable us to identify genetic factors underlying the transition from exposure to addiction.
Heroin dependence might have common features with other drug dependence disorders. For example, the multistaged process leading to dependence has been investigated in more detail for nicotine dependence. Here, it has been shown that genetic factors are important in the transition stage from initial use to drug dependence (Sullivan and Kendler, 1999) . Similar data Linkage disequilibrium block structure generated using Haploview 4.2 and confidence intervals. (Agrawal and Lynskey, 2006) , as well as in a study of initiation and subsequent abuse of illicit drugs in women . In addition, a series of twin studies for alcohol and nicotine dependence (Stallings et al., 1999) , and for illicit drugs, including heroin (Tsuang et al., 1998) suggested, that genetic factors could be more important in transition than in initiation of drugs of abuse. Histogram showing the distribution of time for the quantitative parameter time interval from occasional to regular heroin use in years. CamK2A and heroin dependence Eirich et al. 23
A number of quality controls were used to assure confidence in the reported results. First, genotyping included about 10% of duplicated samples. No discrepancies in genotypes were detected. Second, we used ancestry informative markers in an attempt to confirm the selfreported ethnicity. This is important to avoid biased results due to population caused variation of allele frequencies. Third, we used the ancestry informative markers for the detection of a hidden relationship between study participants, which may bias allele and genotype frequencies, leading to population rather than phenotype association.
Even though the number of ancestry informative markers was low, we could make adjustments in terms of ethnic homogeneity of the sample, as well as with regard to the independence of individuals. However, for a more accurate estimation of ethnic differences in allele frequencies, and for identification of the descent status for detection of hidden relationship, more than 100 000 genetic variants would have been necessary (Purcell et al., 2007) .
Limitations of our approach are related to the phenotype that is based on self-reporting. Although all of our study participants were diagnosed with heroin dependence using diagnostic guidelines (DSM-IV), we have not been able to corroborate the time point of onset of heroin dependence using the diagnostic manual, nor were we able to independently confirm the time point of first use of heroin. This may have confounded the quantitative phenotype. In addition, quantitative data were not normally distributed. When deleting samples with a reported occasional to regular heroin use of more than 5 years (i.e. outliers based on the distribution of data), P values increased and only rs4958468 (P = 0.03) was still nominally significant, whereas rs10066581 showed a marginal significant P value of 0.06. The increase in P values may be due to the reduced power of the sample (N = 515).
We focused our analysis on the gene encoding the enzyme CamK2A, which had been reported to be linked to learning and memory. This enzyme is involved in hippocampal long-term potentiation and spatial learning (Colbran and Brown, 2004) . There is some support from animal models for the involvement of CamKII in drug dependence. It has been shown, that induced morphine sensitization modulated the mRNA expression of CaMKII in the hippocampus of rats (Kadivar et al., 2014) . Moreover, CamK2A had been implicated in cocaine dependence before (Easton et al., 2014) . It had been shown that carriers of an intronic variant located within this gene (rs3776823-TT) undergo a faster transition to severe cocaine use. We were unable to show an influence of this specific variant in our study. However, we found a shorter self-reported time interval between occasional and regular heroin use for carriers of the major G-allele of rs10066581. This variant is located~22 kb upstream of rs3776823 in intron 15 of the CamK2A gene. These findings suggest that transition time may be influenced by genetic variants in this gene.
We have used PLINK for single marker association analysis using a quantitative parameter. Taking the LD block structure of the genomic region into account, we have explored the relationship between haplotypes and the time interval between occasional and regular heroin use with the program FAMHHAP (Becker and Knapp, 2004a; Herold and Becker, 2009 ). Haplotype trend regression for quantitative traits and 10 000 permutations, implemented in FAMHAP yielded corrected P values against the global null hypothesis that none of the marker combinations is associated with the phenotype. Explorative descriptive statistics using haplotype frequencies as estimated in FAMHAP (Becker and Knapp, 2004b) , revealed further support for results obtained with PLINK.
No function for variant rs10066581 has been reported in current databases. We used RegRNA v2.0 (Huang et al., 2006) to identify possible relevant regulatory RNA motifs. We found the G-allele of rs10066581 as a transcriptional regulatory motif. Specifically, it serves as a binding site for the transcriptional enhancer C/EBPdelta. Presence of this intronic transcriptional enhancer motif may be important in fine-tuning the transcriptional activity of CAMK2A, impacting synaptic plasticity. Homozygote carriers of the G-allele for this specific polymorphism revealed on average a shorter transition time to regular heroin use (1.6 years) versus carriers of the A-allele (4.1 years), which may support the idea that a stronger transcription of CamK2A may strengthen memory formation earlier or faster. Further experiments and analyses are necessary to support or refute this hypothesis.
Conclusion
In this study, we focused on a subphenotype of heroin dependence, the time interval between occasional and regular heroin use, where genetic factors might play a substantial role. To address this, we performed quantitative trait analysis. Our results suggest that variants located in the CamK2A gene may contribute to transition from occasional to regular heroin use. If confirmed, the Samples were grouped according to presence/absence of haplotype 3 (composed of minor allele 'A' for rs10066581 and major allele 'G' for rs6869634).
finding may help in the management of heroin dependence.
